Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lessons of the month 1: Longitudinal extensive transverse myelitis following AstraZeneca COVID-19 vaccination.

Literature DB >> 34507942

Lessons of the month 1: Longitudinal extensive transverse myelitis following AstraZeneca COVID-19 vaccination.

Alp Aa Notghi¹, Joseph Atley², Mark Silva².

Abstract

Longitudinal extensive transverse myelitis (LETM) is a rare but recognised complication of vaccination. We report the case of a 58-year-old man admitted to hospital 10 days after his first AstraZeneca COVID-19 vaccination with progressive neurological symptoms and signs, and investigations and imaging consistent with LETM.This case reviews the literature and the investigative process behind excluding other diagnoses given the patient's background of pulmonary sarcoidosis. It is unique in being the first UK report of a case of LETM with a strong temporal link to COVID-19 vaccination. © Royal College of Physicians 2021. All rights reserved.

Entities: Chemical

Keywords: AstraZeneca; COVID-19; longitudinal extensive transverse myelitis; myelitis; vaccination

Mesh：

Substances：
COVID-19 Vaccines

Year: 2021 PMID： 34507942 PMCID： PMC8439525 DOI： 10.7861/clinmed.2021-0470

Source DB: PubMed Journal: Clin Med (Lond) ISSN： 1470-2118 Impact factor: 5.410

5 in total

Review 1. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Authors: Alan J Thompson; Brenda L Banwell; Frederik Barkhof; William M Carroll; Timothy Coetzee; Giancarlo Comi; Jorge Correale; Franz Fazekas; Massimo Filippi; Mark S Freedman; Kazuo Fujihara; Steven L Galetta; Hans Peter Hartung; Ludwig Kappos; Fred D Lublin; Ruth Ann Marrie; Aaron E Miller; David H Miller; Xavier Montalban; Ellen M Mowry; Per Soelberg Sorensen; Mar Tintoré; Anthony L Traboulsee; Maria Trojano; Bernard M J Uitdehaag; Sandra Vukusic; Emmanuelle Waubant; Brian G Weinshenker; Stephen C Reingold; Jeffrey A Cohen
Journal: Lancet Neurol Date: 2017-12-21 Impact factor: 44.182

Review 2. Neuromyelitis optica spectrum disorders.

Authors: Saif Huda; Dan Whittam; Maneesh Bhojak; Jayne Chamberlain; Carmel Noonan; Anu Jacob
Journal: Clin Med (Lond) Date: 2019-03 Impact factor: 2.659

3. Longitudinally extensive transverse myelitis following vaccination with nasal attenuated novel influenza A(H1N1) vaccine.

Authors: Wafa Akkad; Bassel Salem; Jerome W Freeman; Mark K Huntington
Journal: Arch Neurol Date: 2010-08

Review 4. Transverse myelitis and vaccines: a multi-analysis.

Authors: N Agmon-Levin; S Kivity; M Szyper-Kravitz; Y Shoenfeld
Journal: Lupus Date: 2009-11 Impact factor: 2.911

5. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

Authors: Merryn Voysey; Sue Ann Costa Clemens; Shabir A Madhi; Lily Y Weckx; Pedro M Folegatti; Parvinder K Aley; Brian Angus; Vicky L Baillie; Shaun L Barnabas; Qasim E Bhorat; Sagida Bibi; Carmen Briner; Paola Cicconi; Andrea M Collins; Rachel Colin-Jones; Clare L Cutland; Thomas C Darton; Keertan Dheda; Christopher J A Duncan; Katherine R W Emary; Katie J Ewer; Lee Fairlie; Saul N Faust; Shuo Feng; Daniela M Ferreira; Adam Finn; Anna L Goodman; Catherine M Green; Christopher A Green; Paul T Heath; Catherine Hill; Helen Hill; Ian Hirsch; Susanne H C Hodgson; Alane Izu; Susan Jackson; Daniel Jenkin; Carina C D Joe; Simon Kerridge; Anthonet Koen; Gaurav Kwatra; Rajeka Lazarus; Alison M Lawrie; Alice Lelliott; Vincenzo Libri; Patrick J Lillie; Raburn Mallory; Ana V A Mendes; Eveline P Milan; Angela M Minassian; Alastair McGregor; Hazel Morrison; Yama F Mujadidi; Anusha Nana; Peter J O'Reilly; Sherman D Padayachee; Ana Pittella; Emma Plested; Katrina M Pollock; Maheshi N Ramasamy; Sarah Rhead; Alexandre V Schwarzbold; Nisha Singh; Andrew Smith; Rinn Song; Matthew D Snape; Eduardo Sprinz; Rebecca K Sutherland; Richard Tarrant; Emma C Thomson; M Estée Török; Mark Toshner; David P J Turner; Johan Vekemans; Tonya L Villafana; Marion E E Watson; Christopher J Williams; Alexander D Douglas; Adrian V S Hill; Teresa Lambe; Sarah C Gilbert; Andrew J Pollard
Journal: Lancet Date: 2020-12-08 Impact factor: 79.321

5 in total

14 in total

1. Incomplete Subacute Transverse Myelitis Following Vaccination With Pfizer-BioNTech COVID-19 mRNA Vaccine: A Case Report.

Authors: Jarrah Alabkal; Alexander D Rebchuk; Daniel Lyndon; Nikkie Randhawa
Journal: Cureus Date: 2021-12-16

2. Transverse myelitis: a diagnostic challenge.

Authors: Tarig Abkur; Mamoun Saeed
Journal: Clin Med (Lond) Date: 2021-11 Impact factor: 2.659

Review 3. COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review.

Authors: Naim Mahroum; Noy Lavine; Aviran Ohayon; Ravend Seida; Abdulkarim Alwani; Mahmoud Alrais; Magdi Zoubi; Nicola Luigi Bragazzi
Journal: Front Immunol Date: 2022-07-05 Impact factor: 8.786

Review 4. Clinical characteristics, radiological features and prognostic factors of transverse myelitis following COVID-19 vaccination: A systematic review.

Authors: Vahid Reza Ostovan; Mohammad Ali Sahraian; Neda Karazhian; Mahtab Rostamihosseinkhani; Marzieh Salimi; Hoda Marbooti
Journal: Mult Scler Relat Disord Date: 2022-07-06 Impact factor: 4.808

Review 5. The association between SARS-CoV-2 vaccines and transverse myelitis: A review.

Authors: Fatima Naz Naeem; Syeda Fatima Saba Hasan; Muskaan Doulat Ram; Summaiyya Waseem; Syed Hassan Ahmed; Taha Gul Shaikh
Journal: Ann Med Surg (Lond) Date: 2022-06-09

6. Extensive Longitudinal Transverse Myelitis Temporally Related to the Use of AZD1222, AstraZeneca COVID-19 Vaccine: Cerebrospinal Fluid Analysis and Recent Data Review.

Authors: Paulo Diniz da Gama; Tiago Gomes de Alcantara; Rafaela Ramos Smaniotto; Penélope de Lima Petuco; Wammer Alves de Almeida; Rodrigo Assad Diiniz da Gama; Yara Dadalti Fragoso
Journal: Case Rep Neurol Med Date: 2022-06-10